Literature DB >> 30719193

Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.

Wade Thompson1,2,3,4,5,6,7, Barbara Farrell1,2,3,4,5,6,7, Vivian Welch1,2,3,4,5,6,7, Peter Tugwell1,2,3,4,5,6,7, Cynthia Way1,2,3,4,5,6,7, Lisa Richardson1,2,3,4,5,6,7, Lise M Bjerre1,2,3,4,5,6,7.   

Abstract

Entities:  

Year:  2018        PMID： 30719193      PMCID： PMC6346337          DOI： 10.1177/1715163518816719

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  11 in total

1.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Decision Aid Use in Primary Care: An Overview and Theory-Based Framework.

Authors:  Cameron G Shultz; Masahito Jimbo
Journal:  Fam Med       Date:  2015-10       Impact factor: 1.756

3.  Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.

Authors:  Wade Thompson; Barbara Farrell; Vivian Welch; Peter Tugwell; Lise M Bjerre
Journal:  Can Pharm J (Ott)       Date:  2016-11-30

4.  Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.

Authors:  Emily Reeve; Jane M Andrews; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  Ann Pharmacother       Date:  2014-11-10       Impact factor: 3.154

Review 5.  The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

Authors:  Daniel E Freedberg; Lawrence S Kim; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2017-03       Impact factor: 22.682

6.  Community-dwelling older people's attitudes towards deprescribing in Canada.

Authors:  Caroline Sirois; Nicole Ouellet; Emily Reeve
Journal:  Res Social Adm Pharm       Date:  2016-08-31

Review 7.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

Review 8.  Decision aids for people facing health treatment or screening decisions.

Authors:  Dawn Stacey; France Légaré; Nananda F Col; Carol L Bennett; Michael J Barry; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; Richard Thomson; Lyndal Trevena; Julie H C Wu
Journal:  Cochrane Database Syst Rev       Date:  2014-01-28

9.  Translating Evidence to Facilitate Shared Decision Making: Development and Usability of a Consult Decision Aid Prototype.

Authors:  Dawn Stacey; France Légaré; Anne Lyddiatt; Anik M C Giguere; Manosila Yoganathan; Anton Saarimaki; Jordi Pardo Pardo; Tamara Rader; Peter Tugwell
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

Review 10.  Establishing the effectiveness of patient decision aids: key constructs and measurement instruments.

Authors:  Karen R Sepucha; Cornelia M Borkhoff; Joanne Lally; Carrie A Levin; Daniel D Matlock; Chirk Jenn Ng; Mary E Ropka; Dawn Stacey; Natalie Joseph-Williams; Celia E Wills; Richard Thomson
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796
View more
  7 in total

Review 1.  Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review.

Authors:  Jérôme Nguyen-Soenen; Cédric Rat; Jean-Pascal Fournier
Journal:  Eur J Clin Pharmacol       Date:  2019-11-06       Impact factor: 2.953

2.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

3.  Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.

Authors:  Wade Thompson; Ida Theemann Jacobsen; Dorte Ejg Jarbøl; Peter Haastrup; Jesper Bo Nielsen; Carina Lundby
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

4.  Characteristics of Pharmacists' Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study.

Authors:  A L Yailian; E Huet; B Charpiat; O Conort; M Juste; R Roubille; M Bourdelin; J Gravoulet; C Mongaret; C Vermorel; P Bedouch; A Janoly-Duménil
Journal:  Int J Clin Pract       Date:  2022-06-28       Impact factor: 3.149

Review 5.  Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies.

Authors:  Claudia C Orelio; Pauline Heus; Judith J Kroese-van Dieren; René Spijker; Barbara C van Munster; Lotty Hooft
Journal:  J Gen Intern Med       Date:  2021-02-02       Impact factor: 5.128

6.  Exploring implementation processes in general practice in a feedback intervention aiming to reduce potentially inappropriate prescribing: a qualitative study among general practitioners.

Authors:  Kirsten Høj; Anna Mygind; Flemming Bro
Journal:  Implement Sci Commun       Date:  2021-01-07

Review 7.  Deprescribing practices in Canada: A scoping review.

Authors:  Mansi Desai; Tanya Park
Journal:  Can Pharm J (Ott)       Date:  2022-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.